Literature DB >> 22426372

Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage.

Pedro Plans-Rubió1.   

Abstract

The necessary herd immunity blocking the transmission of an infectious agent in the population is established when the prevalence of protected individuals is higher than a critical value, called the herd immunity threshold. The establishment of herd immunity in the population can be determined using the vaccination coverage and seroepidemiological surveys. The vaccination coverage associated with herd immunity (V(c)) can be determined from the herd immunity threshold and vaccine effectiveness. This method requires a vaccine-specific effectiveness evaluation, and it can be used only for the herd immunity assessment of vaccinated communities in which the infectious agent is not circulating. The prevalence of positive serological results associated with herd immunity can be determined from the herd immunity threshold, in terms of prevalence of antibodies (p(c)) and serological test performance. The herd immunity is established when the prevalence of antibodies is higher than pc. This method can be used to assess the establishment of herd immunity in different population groups, both when the infectious agent is circulating and when it is not possible to assess vaccine effectiveness. The herd immunity assessment in Catalonia, Spain, showed that the additional vaccination coverage required to establish herd immunity was 3-6% for measles, mump and varicella and 11% poliovirus type III in school children, 17-59% for diphtheria in youth and adults and 25-46% for persussis in school children, youth and adults.

Entities:  

Mesh:

Year:  2012        PMID: 22426372     DOI: 10.4161/hv.18444

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  40 in total

1.  Ethics and Childhood Vaccination Policy in the United States.

Authors:  Kristin S Hendrix; Lynne A Sturm; Gregory D Zimet; Eric M Meslin
Journal:  Am J Public Health       Date:  2015-12-21       Impact factor: 9.308

2.  Clinical characteristics and pertussis costs in cases reported to epidemiological services and cases detected in household contacts in Catalonia (Spain).

Authors:  P Plans; C Muñoz-Almagro; P Godoy; M Jané; G Carmona
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-30       Impact factor: 3.267

3.  Clinical and Epidemiological Aspects of Diphtheria: A Systematic Review and Pooled Analysis.

Authors:  Shaun A Truelove; Lindsay T Keegan; William J Moss; Lelia H Chaisson; Emilie Macher; Andrew S Azman; Justin Lessler
Journal:  Clin Infect Dis       Date:  2020-06-24       Impact factor: 9.079

4.  The effectiveness of measles-mumps-rubella (MMR) vaccination in the prevention of pediatric hospitalizations for targeted and untargeted infections: A retrospective cohort study.

Authors:  Giuseppe La Torre; Rosella Saulle; Brigid Unim; Angela Meggiolaro; Angelo Barbato; Alice Mannocci; Antonietta Spadea
Journal:  Hum Vaccin Immunother       Date:  2017-06-12       Impact factor: 3.452

5.  New preventive strategy to eliminate measles, mumps and rubella from Europe based on the serological assessment of herd immunity levels in the population.

Authors:  P Plans
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-02-16       Impact factor: 3.267

Review 6.  A review of factors affecting vaccine preventable disease in Japan.

Authors:  Norimitsu Kuwabara; Michael S L Ching
Journal:  Hawaii J Med Public Health       Date:  2014-12

7.  Serological Susceptibility to Varicella Among U.S. Immigration and Customs Enforcement Detainees.

Authors:  Aiden K Varan; Edith R Lederman; Shanon S Stous; Diana Elson; Jennifer L Freiman; Mona Marin; Adriana S Lopez; William M Stauffer; Rachael H Joseph; Stephen H Waterman
Journal:  J Correct Health Care       Date:  2017-09-25

8.  Measles in Romania - clinical and epidemiological characteristics of hospitalized measles cases during the first three years of the 2016-ongoing epidemic.

Authors:  Daniela Pițigoi; Oana Săndulescu; Maria Dorina Crăciun; Anca Drăgănescu; Gheorghiță Jugulete; Anca Streinu-Cercel; Angelica Vișan; Claudia Rîciu; Alexandru Rafila; Victoria Aramă; Monica Luminos; Adrian Streinu-Cercel
Journal:  Virulence       Date:  2020-12       Impact factor: 5.882

Review 9.  Measles, the need for a paradigm shift.

Authors:  Emilie Javelle; Philippe Colson; Philippe Parola; Didier Raoult
Journal:  Eur J Epidemiol       Date:  2019-10-17       Impact factor: 8.082

10.  Incomplete vaccination coverage in European children with end-stage kidney disease prior to renal transplantation.

Authors:  Britta Höcker; Martin Aguilar; Paul Schnitzler; Lars Pape; Luca Dello Strologo; Nicholas J A Webb; Martin Bald; Gurkan Genc; Heiko Billing; Jens König; Anja Büscher; Markus J Kemper; Stephen D Marks; Martin Pohl; Marianne Wigger; Rezan Topaloglu; Susanne Rieger; Kai Krupka; Thomas Bruckner; Alexander Fichtner; Burkhard Tönshoff
Journal:  Pediatr Nephrol       Date:  2017-10-05       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.